NCT01727128View on ClinicalTrials.gov

Pharmacokinetic Study of BKM120 in Subjects With Hepatic Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Hepatic Impairment
Interventions
DRUG

BKM120

Trial Locations (3)

1618

Novartis Investigative Site, Sofia

14050

Novartis Investigative Site, Berlin

117198

Novartis Investigative Site, Moscow

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY